This study is to investigate the [68Ga]Ga-DOTA-FAPI PET/CT diagnosis performance in biliary tract carcinoma (BTC) and analyze the association between [68Ga]Ga-DOTA-FAPI PET/CT and clinical indexes. A prospective study (NCT 05264688) was performed between January 2022 and July 2022. Fifty participants were scanned using [68Ga]Ga-DOTA-FAPI and [18F]FDG PET/CT and acquired pathological tissue. We employed the Wilcoxon signed-rank test to compare the uptake of [68Ga]Ga-DOTA-FAPI and [18F]FDG, and the McNemar test was used to compare the diagnostic efficacy between the two tracers. Spearman or Pearson correlation was used to assess the association between [68 Ga]Ga-DOTA-FAPI PET/CT and clinical indexes. In total, 47 participants (mean age 59.09 ± 10.98 [range 33–80 years]) were evaluated. The [68Ga]Ga-DOTA-FAPI detection rate was greater than [18F]FDG in primary tumors (97.62

Near-infrared fluorescent cholangiography (NIRFC) with indocyanine green (ICG) as the developer yields clear visualization of the extrahepatic bile ducts and is effective in identifying key structures. Here, we analyzed and compared the surgical outcomes of fluorescent and conventional laparoscopy in cholecystectomy of various difficulties and then assessed the value of NIRFC. This retrospective study collected clinical data from partial patients who underwent laparoscopic cholecystectomy (LC) at the Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University between 2020 and 2021. The study subjects were classified into ICG-assisted and white-light laparoscopy. Two cohorts with homogeneous baseline status were selected based on 1:1 ratio propensity score matching (PSM). Multivariate logistic regression analysis was performed to predict independent risk factors for LC difficulty. Thereafter, the matched cases were classified into difficult and easy subgroups by combining difficulty score and gallbladder disease type, and then the surgical outcomes of the two groups were compared. This study included a total of 624 patients. The patients were classified into the ICG group (n = 218) and the non-ICG group (n = 218) after a 1:1 ratio PSM. Our data showed significant differences between the groups in operative time (P = 0.020), blood loss (P = 0.016), length of stay (P = 0.036), and adverse reaction (P = 0.023). Stratified analysis demonstrated that ICG did not significantly improve the surgical outcomes in simple cases (n = 208). On the other hand, in difficult cases (n = 228), NIRFC shortened operative time (P = 0.003) and length of stay (P = 0.015), reduced blood loss (P = 0.028) and drain placement rate (P = 0.015), and had fewer adverse reactions (P = 0.023). The data showed that five cases were converted to laparotomy while two cases had minor bile leaks in the non-ICG group. There was no bile duct injury (BDI) in all the cases. Furthermore, high BMI, history of urgent admission and abdominal surgery, palpable gallbladder, thickened wall, and pericholecystic collection were risk factors for surgical difficulty. ICG-assisted NIRFC provides real-time biliary visualization. In complicated conditions such as acute severe inflammation, dense adhesions, and biliary variants, the navigating ability of fluorescence can enhance the operation progress, reduce the possibility of conversion or serious complications, and improve the efficiency and safety of difficult LC.

BackgroundIndocyanine green (ICG) fluorescence imaging technology is increasingly widely used in laparoscopic hepatectomy. However, whether it can provide long-term survival benefits to patients with liver malignancies remains unclear. This study investigated the clinical effect of laparoscopic hepatectomy for hepatocellular carcinoma (HCC) using ICG imaging technology.MethodsWe retrospectively analyzed HCC patients who underwent laparoscopic hepatectomy at Zhongnan Hospital of Wuhan University from January 2016 to December 2020. Propensity score matching (PSM) was used to match patients undergoing ICG fluorescence navigation laparoscopic hepatectomy (ICG-FNLH) with those undergoing conventional laparoscopic hepatectomy (CLH) in a 1:1 ratio to minimize the influence of confounding factors. We compared perioperative status and long-term prognosis between the two groups and performed multivariate analysis to identify risk factors associated with overall survival and recurrence-free survival.ResultsThe original cohort consisted of 141 patients, with 50 patients in each group (100 patients in total) after PSM. The anatomical liver resection rate, R0 resection rate, and resection margin distance in the ICG-FNLH group were higher than those in the CLH group. The intraoperative blood loss was lower than that in the CLH group. The recurrence-free survival and overall survival of the ICG-FNLH group were better than those of the CLH group. ICG-FNLH improved the recurrence-free survival of HCC patients (hazard ratio [HR] = 2.165, 95% confidence interval [CI]: 1.136-4.127, P = 0.024).ConclusionsCompared with CLH, ICG-FNLH can improve the recurrence-free survival rate of patients with hepatocellular carcinoma and may help to improve the long-term prognosis of patients.

目的 评估腹腔镜肝右后叶切除的流程化手术方案的安全性和有效性.方法 回顾性分析2020年5月至2023年3月武汉大学中南医院肝胆胰外科行腹腔镜右后叶切除手术47例病人的临床资料、手术信息及病理结果,符合正态分布的计量资料以(x)±s表示,不符合正态分布的计量资料以M(Q1,Q3)表示.以左侧卧体位、优化处理尾状突及右后肝蒂、吲哚菁绿荧光引导、原位断肝、循下腔静脉前间隙和肝右静脉轴线引导肝实质离断平面的"五步法"为要点,实施流程化手术,并对该术式的临床效果展开分析.结果 47例病人均成功完成腹腔镜下流程化右后叶切除手术,其中良性病灶7例,恶性肿瘤40例,包括26例肝细胞癌,肿瘤最大径为12 cm.手术时间为330(138,582)min,肝门阻断时间为60(15,151)min,术中出血量为200.0(100.0,312.5)mL.10例病人出现术后并发症,Clavein-Dindo分级Ⅰ级4例,Ⅱ级6例,无Ⅲ级以上并发症.病人术后住院时间为(8.3±3.0)d.结论 "五步法"流程化腹腔镜肝右后叶切除手术改进了手术区的显露,突出了无瘤操作原则,简化了右后肝蒂的处理,优化了肝实质离断平面把握,安全有效,易于推广.

Supplementary Tables 1-3 from Hypoxia Induces Genomic DNA Demethylation through the Activation of HIF-1α and Transcriptional Upregulation of MAT2A in Hepatoma Cells

目的 探讨急性胰腺炎(acute pancreatitis,AP)病人早期外周血白细胞计数双峰型变化的临床意义.方法 回顾性分析2018年1月至2019年11月武汉大学中南医院肝胆胰外科收治的230例A P病人资料,据病人发病2周内的外周血白细胞计数水平变化,分为单峰组(160例)和双峰组(70例).比较两组病人临床资料.双峰组病人分为感染性胰腺坏死(infected pancreatic necro-sis,IPN)组(19例)和非IPN组(51例),对比两组病人白细胞计数第二峰期的临床资料.采用受试者工作特征(ROC)曲线分析相关指标对IPN的诊断价值.对比IPN组与非IPN组经皮穿刺置管引流术(percutaneous catheter drainage,PCD)术后病人的预后.结果 双峰组病人占全部AP病人的30.4％(70/230).双峰组病人住院时间更长,病死率更高,与单峰组比较差异有统计学意义(P<0.05);与非IPN病人相比,IPN病人更容易出现峰期发热、中性粒细胞与淋巴细胞比值(NLR)升高、红细胞比容(HCT)降低、血清白蛋白降低、淋巴细胞百分比降低及Balthazar CT分级更重,差异均具有统计学意义(均P<0.05);多因素Logistic回归分析显示双峰组病人发生IPN的独立危险因素为:NLR>12.45[OR=1.943,95％CI(1.117,58.157),P=0.047]、发热(腋温>37.3℃)[OR=10.456,95％CI(2.520,300.206),P<0.001],Balthazar CT分级C级以上[OR=17.845,95％CI(3.114,65.435),P=0.005],3项联合诊断其发生IPN的曲线下面积为0.897.双峰后行PCD的病人较未行PCD病人住院时间更长;10例非IPN病人PCD后有4例出现继发感染,较未发生感染病人住院时间更长.结论 白细胞计数双峰型变化在AP病人起病2周内比较常见,但只有少部分病人发生IPN.NLR、Balthazar CT分级联合发热对双峰AP病人发生IPN有很好的诊断价值.非IPN病人行PCD胰周引流可能导致继发感染,延长住院时间.

Background The liver cyst is commonly treated by hepatobiliary surgery. Generally, most patients show no apparent symptoms and often get diagnosed accidentally during the imaging examinations. In addition, most patients with liver cysts follow a benign course, with fewer severe complications and rare occurrences of malignant changes. Therefore, based on disease characteristics and healthcare costs, long-term regular follow-up of liver cysts are rarely performed clinically. Case Description Here, we reported two previously treated or observed cases for liver cysts, where intrahepatic neoplastic lesions were found unexpectedly at the liver cyst during follow-up. These two patients’ clinical manifestations and laboratory examinations lacked specificity with unclear pre-operative diagnosis, whereas the post-operative pathology confirmed cholangiocarcinoma. One of the patients was a 64-year-old female with right upper abdominal distension. She underwent cyst fenestration for a liver cyst 3 years ago. In the latest admission, imaging examination revealed a tumor in the left inner lobe of the liver. The tumor was located in the exact fenestration location, and the pathological diagnosis of cholangiocarcinoma was made after surgical resection. The patient received Lenvatinib post-operatively and had no recurrence during the follow-up. Another patient, a 68-year-old woman, was asymptomatic, but the liver margin was palpable under the ribs on her physical examination. She had a previous diagnosis of liver cysts and was on regular yearly follow-up. In the last follow-up, a tumor was found close to a cyst. It was diagnosed as intrahepatic cystadenocarcinoma before surgery; however, the pathological features after surgical resection were more consistent with the cholangiocarcinoma. The patient had lung metastases 2 months after the surgery, but her condition improved after receiving targeted therapy and immunotherapy. Moreover, she is alive to this day. Conclusions We reported 2 cases of intrahepatic cholangiocarcinoma discovered accidentally during the follow-up of hepatic cysts. The location of the malignant tumor coincided with the location of the cyst, making the clinical differential diagnosis problematic. Therefore, it is necessary to be vigilant about the possibility of combined malignant tumors for the follow-up of complex cysts, as early detection and treatment may help improve the prognosis of these patients. After surgery, multimodal therapy, including chemotherapy, immunotherapy, and targeted therapy, is helpful.

Laparoscopic right posterior hepatectomy is considered difficult on the basis of the surgery difficulty scoring system. In this study, we evaluated the safety and effectiveness of the technical application of indocyanine green (ICG) fluorescence imaging-guided laparoscopic right posterior hepatectomy. Twenty-six patients who underwent ICG fluorescence imaging-guided laparoscopic right posterior hepatectomy at Hepatobiliary and Pancreatic Surgery Department of Zhongnan Hospital, Wuhan University, from June 2018 to December 2019, were included. The influence of patient position, trocar placement, hepatic inflow occlusion, central venous pressure (CVP), and the ICG fluorescence imaging-guided method were analyzed. In 17 patients, the left lateral position was maintained when the main tumor was in the S7, and in the remaining nine patients, the supine position was maintained with the right side of the body raised when the main tumor was in the S6. Ten patients who underwent preoperative injection of ICG were successfully developed for nonanatomical hepatectomy. Sixteen patients received intraoperative ICG injection for anatomical hepatectomy (2 cases had positive imaging findings, 14 cases had negative imaging findings, and 2 cases had failed imaging findings). All patients underwent the Pringle maneuver during the procedure. Four patients were preset with subhepatic vena cava blocking and one patient with suprahepatic inferior vena cava blocking. CVP was controlled at 3.00 ± 0.63 (mean ± SD) cmH2O. The operative time was 216.14 ± 52.05 min, and the bleeding volume was 128.57 ± 75.55 ml. Four patients had Clavien–Dindo level I complications, and one had level III complications. Postoperative hospitalization duration was 6.19 ± 1.40 days. There were 14 patients with hepatocellular carcinoma, 9 with metastatic liver malignancies, 2 with hepatic hemangioma, 1 with focal nodular hyperplasia of the liver, and 10 with hepatitis B liver cirrhosis. ICG fluorescence imaging guidance could be helpful for the safe implementation of laparoscopic right posterior hepatectomy.

目的 探讨肝门部胆管癌根治术中联合血管切除重建的安全性和有效性.方法 回顾性分析2014年6月至2019年12月武汉大学中南医院收治的113例确诊为肝门部胆管癌的病人,包括行姑息治疗50例(姑息治疗组),行开腹肝门部胆管癌根治术63例,其中行联合血管切除重建的肝门部胆管癌根治术26例(联合血管切除重建组),行常规肝门部胆管癌根治术37例(常规根治组).比较常规根治组及联合血管切除重建组两组病人的手术时间、术中出血量、是否术中输血、术后肝功能恢复情况、术后严重并发症发生率、住院时间等围手术期情况以及两组病人术后90 d生存率,同时亦比较姑息治疗组、常规根治组、联合血管切除重建组三组病人术后1、3、5年的总生存率.结果 联合血管切除重建组病人手术时间、术中出血量和术中输血率均高于常规根治性切除组(P＜0.05),但在并发症发生率、住院时间以及术后90 d生存率差异无统计学意义(P＞0.05);常规根治组在术后第1、3、5天丙氨酸转氨酶(ALT)以及术后第1、3天天冬氨酸转氨酶(AST)低于联合血管切除重建组(P＜0.05),但在术后第7天的ALT值及术后第5 天、第7 天的AST值差异无统计学意义(P＞0.05);此外两手术组病人术后1、3、5年总存活率差异无统计学意义(P＞0.05),但两组病人术后1、3、5年总生存率均明显高于姑息治疗组(P＜0.01).结论 在仔细评估、选择合适病例前提下,肝门部胆管癌根治术中联合血管切除重建是安全的,而且可获得与不需要血管切除重建的肝门部胆管癌手术病人相似的疗效,行根治性手术的病人疗效优于行姑息性治疗的病人.

目的 探索肝脏术后严重肝缺血或淤血对病人生存预后的影响,探讨病情恢复过程中面临的问题和规律,以及临床治疗的关键措施.方法 回顾8例肝脏术后发生严重缺血、淤血性并发症病人,归纳该类并发症的临床病程及治疗要点;通过倾向性评分匹配方法匹配常规手术对照组,分析研究组(8例)和对照组(30例)术后肝功能、术后住院时间和住院费用的差异.结果 与对照组比较,研究组术后肝功能明显下降,术后住院时间和住院费用均明显增高,差异具有统计学意义(P<0.05).经关键性引流、补充血浆制品和白蛋白等治疗,8例病人全部存活,无死亡病例,随访至今未发现严重后遗症.结论 肝缺血、淤血性并发症病人因其一系列病理生理变化导致术后肝功能下降,术后住院时间和住院费用升高,但病人基本可获得较好预后.术前和术中应积极预防该类并发症发生,治疗过程中需注意动态监测病人病情并对病情变化做出及时干预,关键性引流、补充血浆制品和白蛋白可能是治疗中的重要环节.

Background: The liver cyst is a common disease in hepatobiliary surgery. Most patients have no apparent symptoms and are usually diagnosed accidentally during imaging examinations. The vast majority of patients with liver cysts follow a benign course, with very few serious complications and rare reports of malignant changes. Case Presentation: We present two cases of liver cysts that evolved into intrahepatic tumors during the follow-up process. The first patient had undergone a fenestration and drainage operation for the liver cyst, and the cancer was found at the cyst’s position in the third year after the procedure. Microscopically, bile duct cells formed the cyst wall. Tumor cells can be seen on the cyst wall and its surroundings to form adenoid structures of different sizes, shapes, and irregular arrangements, some of which are arranged in clusters. The second patient was regularly rechecked after discovering liver cysts, and a new mass appeared very close to the cyst. The clinical manifestations and laboratory examinations of the two patients lacked specificity, the preoperative diagnosis was unclear, and the postoperative pathology confirmed cholangiocarcinoma. Conclusions: Our cases indicate that liver cysts may lead to the occurrence of malignant intrahepatic cholangiocarcinoma. Therefore, follow-up of particular liver cysts is necessary, and the differential diagnosis of the intrahepatic cystic tumors needs to include cholangiocarcinoma.

新近在中国武汉集中暴发的新型冠状病毒(SARS-CoV-2)所致肺炎(新冠肺炎,WHO定名:COVID-19)疫情严重威胁人民健康,目前已累及25个国家和地区.截至2020年2月13 日,中国累汁确诊病例63 946例,疑似病例10 109例,病死率2.06％.目前认为SARS-CoV-2传播途径主要是飞沫传播和密切接触,尚不能排除气溶胶和粪-口传播的可能.最新研究表明,新冠肺炎具有非常高的传播效率(R0为3.77).按照国家卫生健康委员会的要求,疫情暴发期间外科手术的开展限于急诊手术和限期手术.对于疑似或确诊感染新冠肺炎患者外科手术时如何进行围手术期的防护,目前国内外尚无棚关指南和共识,缺乏可借鉴的成熟经验.据不完全统计武汉大学中南医院与武汉大学人民医院在疫情期间共收治50例围手术期新冠肺炎患者,其中2例为术后确诊新冠肺炎,围手术期导致16名医务等相关人员感染;48例为术前新冠肺炎疑似或确诊患者,围手术期采取针对性的防护措施后术出现医务相关人员的感染.笔者根据中南大学湘雅医院在新冠肺炎流行期间制定的隔离措施和防护经验,结合上述武汉市两所医院的病例资料,探讨在新冠肺炎流行期间医务人员如何进行围手术期规范操作,制定有效的防护措施.

目的 探讨吲哚菁绿(indocyaninegreen,ICG)荧光显影技术在腹腔镜胆囊手术中的临床应用价值.方法 前瞻性选取术前诊断为胆囊结石合并急性胆囊炎 、慢性萎缩性胆囊炎或残余胆囊的56例病人,其中48例于气腹建立后经外周静脉注射ICG,按剂量不同分为0.5 mg组、1 mg组、5 mg组和10 mg组四组(每组各12例);另外8例于术中根据目标胆道容积经胆道注射浓度为0.025 mg/ml ICG,观察术中目标胆管荧光显影的时间 、荧光强度及对手术的指导作用.结果 48例经外周静脉注射ICG的病人,均成功实施腹腔镜胆囊切除术,除0.5 mg组2例病人显影失败外,余均显影成功.0.5 mg组、1 mg组、5 mg组、10 mg组显影时间分别为(53.60±13.73)min、(42.83±7.80)min、(24.92±6.95)min、(23.17±8.11)min.显影时间显示:0.5 mg组长于1 mg组(P=0.01),1 mg组长于5 mg组(P<0.001),差异均具有统计学意义;5 mg组与10 mg组比较差异无统计学意义(P=0.647).0.5 mg组、1 mg组、5 mg组、10 mg组荧光强度分别为(13.03±4.46)AU、(28.38±7.31)AU、(30.44±6.91)AU、(33.16±6.34)AU.荧光强度显示:0.5 mg组弱于1 mg组,差异具有统计学意义(P<0.001),1 mg组与5 mg组、5 mg组与10 mg比较差异均无统计学意义(均P>0.05).8例术中ICG胆道直接注射者,除1例腹腔镜下肝穿刺经肝内胆管注射病人目标胆管显影失败,其余全部显影成功.结论 准确把握ICG用药剂量、途径和时机,有利于提高腹腔镜胆囊手术的安全性,减少胆道并发症的发生.

Background Studies reported that soluble B7-H4 (sB7-H4) was significantly related to the progression and prognosis of inflammatory diseases, and whether sB7-H4 is related to the severity and prognosis of acute pancreatitis (AP) timely has not been reported. Materials and methods Clinical database data of 446 AP patients were retrospectively collected, and the correlation between the expression serum levels of sB7-H4 with inflammatory factors and prognostic scores was analysed in AP patients. Results Soluble B7-H4 was significantly correlated with IL-6, IL-8, TNF-alpha, PCT, CRP levels and WBC count (P < .01), with correlation coefficients ofR = .61, .53, .46, .60, .57 and .47, respectively, and AUCs were 0.905, 0.837, 0.797, 0.858, 0.890, 0.841 and 0.855, respectively. In addition, sB7-H4 was significantly correlated with the Ranson score, APACHE II score and BISAP score (P < .001), with correlation coefficients ofR = .58, .63 and .59, respectively. The AUCs of assessing local complications of AP were 0.908, 0.863, 0.785 and 0.844, respectively; assessing organ failure were 0.872, 0.790, 0.796 and 0.857, respectively; and assessing in-hospital mortality were 0.839, 0.821, 0.796 and 0.823, respectively. Conclusions Soluble B7-H4 could be used as a marker for the diagnosis, severity assessment and poor prognosis assessment of AP patients, which may have potential clinical applications.

BACKGROUND:Postoperative gastrointestinal dysfunction remains a major determinant of the duration of stay after complex abdominal surgery. This study was performed to evaluate the effectiveness of heated fennel therapy in accelerating the recovery of gastrointestinal function.METHODS:This surgeon-blinded, prospective randomized controlled study included 381 patients with hepatobiliary, pancreatic, and gastric tumors who were divided into 2 groups. The patients in the experimental groups received heated fennel therapy, and those in the control groups received heated rice husk therapy. We compared the baseline characteristics, time to first postoperative flatus and defecation, fasting time, duration of postoperative hospital stay, grading of abdominal pain, classification of abdominal distension, inflammatory markers, and nutritional status indicators.RESULTS:The time to first flatus and first defecation and the fasting time were statistically significantly less in the heated fennel therapy group than those in the control groups (P < .05 each); and abdominal distension was also relieved in the experimental groups (P < .001). Heated fennel therapy had no obvious beneficial effect on inflammatory markers but improved the serum albumin (ALB) level of the patients at postop day 9 (P < .001). Among the patients with alimentary tract reconstruction, those in the heated fennel therapy group had a clinically important, lesser hospital stay than those in the control group (9.2 5 ± 5.1 versus 11.1 ± 6.4; P < .023).CONCLUSION:Heated fennel therapy facilitated the gastrointestinal motility function of patients early postoperatively.

Casein kinase 2 (CK2) has become a potential therapeutic target in gastric cancer; however, the underlying mechanism remains incompletely understood. TAp73, a structural homolog of the tumor suppressor p53, acts as a critical regulator of the Warburg effect. Recent study reveals that aberrant CK2 signaling is able to inhibit TAp73 function. Here we determine that TAp73 is overexpressed in AGS-1 but not in SNU-5 gastric cancer cell line as compared with normal gastric cells. In addition, we show that TAp73 expression is required for the maintenance of glucose uptake and lactate release in AGS-1 but not in SNU-5 gastric cancer cells. Importantly, the use of CX-4945, a selective inhibitor of protein kinase CK2, inhibits cell growth and invasion, and promotes cell apoptosis in AGS-1 with decreased TAp73 expression as well as downregulated glucose uptake and lactate release. Although TAp73 knockdown resulted in significant decreases in TAp73 expressions in SNU-5 cell line, no differences in glucose uptake and lactate release were observed between SNU-5 and normal gastric cells. Moreover, TAp73 gene overexpression promotes glucose uptake and lactate release and abolishes the anti-cancer effects of CX-4945 in gastric cancer cell line AGS-1. The impacts of CX-4945 on glycolysis and tumorigenesis were strongly limited in SNU-5 gastric cancer cell line. These findings suggest that CX-4945 elicits an anti-Warburg effects in gastric cancer overexpressing Tap73 and inhibits gastric tumorigenesis.

Rationale: Understanding the roles of small nucleolar RNAs (snoRNAs) in hepatocarcinogenesis will provide new avenues to identify diagnostic and therapeutic targets for hepatocellular carcinoma (HCC). Our previous research confirmed the tumor-suppressive effect of Up-frameshift 1 (Upf1) in HCC. Herein, we examined the expression profiles of snoRNAs regulated by Upf1 in hepatoma cells. Methods: We examined the expression profiles of snoRNAs regulated by Upf1 in hepatoma cells using RNA-sequencing analysis and then investigated the expression and significance of SNORD52 in HCC tissue and different cell lines. The protumorigenic effects of SNORD52 on HCC cells were confirmed both in vitro and in vivo by gain-of-function and loss-of-function assays. RNA pull-down assays and mass spectrometry were used to identify the RNA-binding protein that binds to SNORD52. Results: Many snoRNAs were identified; one of which, the human C/D box small nucleolar RNA SNORD52, was upregulated in HCC tissues and negatively correlated with Upf1 expression, and patients with higher SNORD52 expression had a poor clinical prognosis. SNORD52 promoted HCC tumorigenesis both in vitro and in vivo. Mechanistically, KEGG analysis showed that SNORD52 upregulated a series of cell cycle genes in HCC cells. We further confirmed that SNORD52 upregulated CDK1 by enhancing the stability of CDK1 proteins and that the function of SNORD52 depends on the presence of CDK1. Conclusion: Overall, the present study indicates that SNORD52 could be a potential biomarker for HCC. Targeting the Upf1/SNORD52/CDK1 pathway might have therapeutic potential for HCC.